✦ LIBER ✦

Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) predicts response to adjuvant chemotherapy in breast cancer

✍ Scribed by M. Ihnen; V. Miiller; R.M. Wirtz; C. Schroder; S. Krenkel; I. Witzel; B.W. Lisboa; F. Janicke; K. Milde-Langosch

Book ID: 119598274
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 56 KB
Volume: 6
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(08)70782-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive impact of activated leukocyte

Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer

✍ M. Ihnen; V. Müller; R. M. Wirtz; C. Schröder; S. Krenkel; I. Witzel; B. W. Lisb 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 247 KB

Ability of tumor proliferative activity

Ability of tumor proliferative activity to predict response to adjuvant chemotherapy with perioperative CEF in stage I–II breast cancer

✍ Pronzato, P.; Queirolo, P.; Sertoli, M.R. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 193 KB

STAT1 activation in squamous cell cancer

STAT1 activation in squamous cell cancer of the oral cavity : A potential predictive marker of response to adjuvant chemotherapy

✍ Klaus Laimer; Gilbert Spizzo; Peter Obrist; Guenther Gastl; Thomas Brunhuber; Ge 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 1 views

## Abstract ## BACKGROUND. For patients with squamous cell carcinoma of the oral cavity, both locoregional and distant recurrences are common, and an appropriate adjuvant treatment modality has yet to be defined. Thus, there is an urgent need to identify novel molecular markers with potential prog

Independent role of p53 expression and r

Independent role of p53 expression and reduction in kinetic cell activity in predicting clinical complete response (CR) to primary chemotherapy in breast cancer (BC) patients

✍ A. Bottini; A. Berruti; A. Bersiga; M.P. Brizzi; A. Brunelli; F. Cirillo; S. Agu 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 162 KB